Disziplinforum, Projektbereiche C und Z im Wintersemester 2015/16
Thema: "PSORIASIS and ATOPIC DERMATITIS – CLASSICAL and NEW THERAPEUTIC APPROACHES: What has to be considered in basic research?"
Organisation: Dr. Fiorenza Rancan (TP C04) und Dr. Lars Mundhenk (TP C03)
Datum: Donnerstag, 28. Januar 2016
Zeit: 9:00 -14:00 Uhr (0,5 CP)
Ort: Charité – Universitätsmedizin Berlin, Department of Dermatology and Allergy, Luisenstr. 2, 10117 Berlin, library on the 2nd floor
Veranstaltungssprache: Englisch
Teilnahme und Anmeldung: nur für Mitglieder des SFB 1112; Voranmeldung bitte über Jeannette Getzin / jeannette.getzin (at) fu-berlin.de
Programm:
|
9:00 – 10:30 |
Reports from the Bench |
|
|
10 min. |
Hausmann, Christian |
C02 |
|
10 min. |
Hönzke, Stefan |
C02 |
|
10 min. |
Pischon, Hannah |
C03 |
|
10 min. |
Radbruch, Moritz |
C03 |
|
10 min. |
Frombach, Janna |
C04 |
|
10 min. |
Jung, Dr., Sora |
C05 |
|
10 min. |
Edlich, Alexander |
Z01 |
|
10 min. |
Gerecke, Dr., Christian |
Z01 |
|
10 min. |
Neumann, Falko |
Z01 |
|
10:30 - 11:00 |
COFFEE BREAK |
|
|
11:00 - 12:45 |
PSORIASIS and ATOPIC DERMATITIS - NEW THERAPEUTIC APPROACHES: What has to be considered in basic research? |
|
|
15 min |
Introduction: F. Rancan: Nucleic acids for the treatment of skin diseases |
|
|
15 min |
Introduction: L. Mundhenk: Antibodies targeting IL-17A, IL-22 and the IL-4 receptor |
|
|
1h 15 min |
Group Work: A) Suitable Analytic Methods for New Biopharmaceuticals |
|
|
Group Work: B) Suitable in vitro Models for New Biopharmaceuticals |
|
|
|
Group Work: C) Suitable in vivo Models for New Biopharmaceuticals |
|
|
|
Group Work: D) Suitable Toxicity Tests for New Biopharmaceutical-Nanocarriers |
|
|
|
12:45 - 13:00 |
COFFEE REFILL |
|
|
13:00-14:00 |
Presentation of the Group Work and Discussion |
|